S epsis, along with its sequelae, is a common cause of morbidity and mortality in children. Septic shock is characterized by perturbations of cardiac function and/or peripheral vascular tone. Cardiac dysfunction in septic shock can be manifested by systolic and/or diastolic dysfunction (1-6). Some studies have found that younger children are more likely to have alterations primarily in cardiac function whereas older children are more likely to have alterations in peripheral vascular tone (7-9). These changes are reversible in the majority of patients,
with cardiac function returning to normal within 7-10 days in survivors and vasculopathy improving along a similar time period (3, 5, 8) . Despite this recovery, secondary organ failure may still lead to significant morbidity and mortality (10) .
Echocardiography can provide noninvasive measures of cardiac performance in children with septic shock. Wall stress analysis and ejection phase indexes allow for accurate assessments of ventricular systolic performance. Serial echocardiograms in pediatric patients with septic shock demonstrate intrinsic ventricular dysfunction in the majority of patients despite adequate volume resuscitation (8, 11) . Echocardiography variables were found to normalize by 6 days in survivors, which is similar to the experience in adults with septic shock (8, 11, 12) . Right heart catheterization can also reliably provide information about preload, afterload, and contractility. In children, however, catheterization requires skilled operators for effective use and is associated with some risk of morbidity (13) .
The mechanisms underlying the myocardial dysfunction of sepsis are not fully understood. Coronary artery disease leading to occult myocardial ischemia may play a role in adults but is an unlikely mechanism in previously healthy children (4) . Direct myocardial cytotoxicity of the products of septic shock or the actions of various mediators of sepsis, including cytokines, have been implicated as causative agents in adults and children (14 -20) . To investigate the role of myocardial cell injury in children with septic shock, we measured serum concentrations of troponin I (TnI). TnI is a protein released by cardiomyocytes after cellular injury, and we hypothesized that TnI would be increased in children with septic shock. We hypothesized that TnI would correlate with measures of cardiac dysfunction measured by echocardiography and clinical variables (including requirement for inotropic support and vasopressors, measures of disease severity, and the number of organ system failures).
MATERIALS AND METHODS
The Institutional Review Board of Children's National Medical Center approved this study. Patients admitted to the pediatric intensive care unit between January 2002 and February 2003 were eligible for this study. Informed consent from the parent or guardian and assent from the patient (if applicable) were obtained before study enrollment. Consecutive children ages 3 months to 18 yrs who met American College of Chest Physicians/ Society of Critical Care Medicine consensus criteria for septic shock and cardiovascular failure were screened for enrollment (21) . Using these consensus criteria, cardiovascular failure was defined as the requirement for inotropic support after adequate fluid resuscitation as determined by the clinical care team. A 12-lead electrocardiogram (EKG) was performed before study enrollment and was interpreted by an attending cardiologist. Since serum TnI would be increased during myocardial ischemia, patients with evidence of ischemia on EKG were excluded from the study. Infants Ͻ3 months of age can also have increased TnI without pathophysiologic abnormalities and were therefore excluded (22) . Last, patients with primary conditions associated with myocardial ischemia or cell injury were also excluded (these included diagnoses of cardiomyopathy, myocarditis, pericarditis, endocarditis, cardiothoracic surgery or trauma within the past 14 days, Kawasaki's disease, congenital heart disease associated with an increased risk of myocardial infarction, and cardiopulmonary resuscitation (cardioversion and defibrillation within the previous 14 days). Because of these stringent enrollment criteria, five children who received cardiopulmonary resuscitation, two children who had EKG changes consistent with acute myocardial ischemia, and one child whose parents refused consent were screened but not enrolled. Additionally, two children died of cardiac arrest while the screening process was ongoing.
Blood for TnI determination was obtained after consent was obtained and entry criteria were met. In the vast majority of cases, entry criteria were met within the first several hours of pediatric intensive care unit admission. Serial samples were obtained from indwelling vascular catheters at admission into the study and then at 12, 24, 48, and 72 hrs after study admission as long as patients satisfied enrollment criteria. Serum TnI was determined using the Bayer I Immunoassay (Bayer Corporation, Tarrytown, NY). The Bayer I Immunoassay uses a sandwich immunoassay format whereby TnI antibody conjugates and monoclonal immunomagnetic antibodies are reacted with the patients' serum. This assay is substantially more sensitive in measuring TnI than previous assays, and therefore cutoff values Ն0.1 ng/mL were considered indicative of myocardial injury. Both our laboratory and the manufacturer consider levels Ͻ0.1 ng/mL to be "nondectectable." For the purpose of this article and for statistical analysis, we have arbitrarily assigned these nondetectable levels the value of 0.09 ng/mL. The reproducibility of these measurements as well as the pediatric reference range of TnI has been previously reported from our laboratory (22) .
Echocardiograms (Sonos 5500, Philips Medical Systems, Andover, MA) were performed on all patients within 24 hrs of study entry by a sonographer without knowledge of TnI concentrations. Fluid resuscitation was completed, and the patients were maintained on vasoactive support at the time of the echocardiogram. Standard measures of left ventricular systolic function including ejection fraction (EF) and fractional shortening (FS) were calculated, in the case of EF by using a twodimensional apical four-chamber view in accordance with Simpson's rule and in the case of FS by standard M mode (23) . Preload and heart rate independent left ventricular systolic function was assessed using heart rate corrected mean velocity of circumferential fiber shortening (Vcf c ), and afterload was assessed by calculation of end-systolic wall stress (WS). Standard M mode calculations and blood pressure measurements were used for both Vcf c (circ/sec) and WS (g/cm 2 ) (24, 25) . To ensure reliable interpretation of echocardiographic data, a single cardiologist (CAS) performed all of the analysis of this data, while remaining blinded to TnI results.
Patient demographics were recorded from the medical record. Requirement for inotropic or vasoactive support was arbitrarily stratified as low (5-10 g/kg/min of dopamine), moderate (11-15 g/kg/min of dopamine), or high (Ͼ15 g/kg/min or any dose of epinephrine or norepinephrine) for data analysis. During this study, no patients received phosphodiesterase inhibitors. Severity of illness was assessed by Pediatric Risk of Mortality (PRISM) III at 12 hrs after hospital admission (26) . The total number of organ system failures (OSF) for the septic episode was calculated according to the criteria of Wilkinson et al. (10) .
Nonparametric testing was performed using SAS software. TnI values Ն0.1 ng/mL were considered abnormally increased. and those Ͻ0.1 ng/mL were converted to 0.09 ng/mL for statistical analysis, based on the manufacturer's recommendations and published norms from noncritically ill children. Requirement for inotropic support was converted to ordinal data with low ϭ 0, moderate ϭ 1, and high ϭ 2. Relationships between variables were analyzed using Pearson's correlation coefficient. After preliminary analysis, patients were then stratified into those with increased admission TnI (TnI positive) and patients with normal admission TnI (TnI negative). Differences between the two groups were analyzed using a Student's t-test.
RESULTS
A total of 23 patients were enrolled (14 females and nine males, median age 9 yrs, range 6 months to 16 yrs), and patient demographics are summarized in Table  1 . Median PRISM III score was 12.0 (range, . Ten of 23 patients required mechanical ventilation, whereas 12 of 23 patients required multiple inotropes/ vasopressors. Fifteen of 23 patients had two or more organ failures, and the 28-day mortality rate was 4.3%. Eightyseven TnI measurements were obtained from these children overall, and 37 (43%) were increased compared with published controls. TnI was increased on study admission in 13 of 23 patients (57%) and at 12 hrs in ten of 22 patients (46%). TnI was maximal within 12 hrs after study enrollment for most patients and was still increased above normal threshold values for three patients at 72 hrs (see Fig. 1 ).
Increased admission TnI was associated with decreased EF and FS (r ϭ Ϫ.66, p ϭ .0022 and r ϭ Ϫ.58, p ϭ .0079, respectively). Increased admission TnI was associated with increased WS (r ϭ .78, p ϭ .0003). Admission TnI and Vcf c were not significantly associated. Admission TnI was not significantly associated with an increased requirement for inotropes and vasoactive medications. Admission TnI correlated with increased disease severity as measured by PRISM III (r ϭ .50, p ϭ .0150) and with OSF (r ϭ .61, p ϭ .0018). Increased TnI at time points after admission was not associated with changes in echocardiographic findings or requirements for inotropic or vasoactive support. However, TnI at 12 hrs and 24 hrs had a strong relationship with OSF (r ϭ .79, p ϭ .0001 and r ϭ .76, p ϭ .0001, respectively).
After patients were stratified into admission TnI groups, mean Vcf c was decreased and mean WS was increased in TnI-positive children compared with TnInegative children (Vcf c , 1.25 Ϯ 0.16 vs. 1.32 Ϯ 0.06, p ϭ .0196; WS, 52 Ϯ 3 vs. 33 Ϯ 4, p ϭ .0052). PRISM III score and requirement for inotropic support were not different after stratification, but mean EF and FS and the number of OSF approached significance (Table 2 ).
DISCUSSION
Clinical markers that are associated with organ failure and severity of illness during sepsis can be important tools for clinicians, researchers, and families. Knowing which patients would likely develop organ failure alerts clinicians to patients at risk. Researchers could effectively stratify patients earlier in the course of their disease to treatment groups for therapies with risks as well as
TnI has several properties that make it an ideal candidate as a serum marker of injury. TnI is the inhibitory subunit of the troponin complex of the cardiomyocyte contractile apparatus and functions as an inhibitor of the calcium-regulated actin-myosin cross-bridge formation. Injury or death of cardiomyocytes disrupts the myocardial cellular membrane, and TnI is released into the cardiac interstitium. Within minutes to hours, TnI can be detected in serum and lymphatics (27, 28) . Since TnI is exclusively localized to the myocardium and its excretion is independent of renal and liver metabolism, it is an extremely sensitive and specific marker for cardiac myocyte injury and death (27) (28) (29) . TnI can be measured using immunoassays with a high reliability (sensitivity and specificity Ͼ98%) in only a few hours (29, 30) . Because of the rapidly available data from these assays and the high specificity of TnI to myocardial injury, TnI has become a commonly used marker for myocardial infarction and other forms of cardiac injury (31) (32) (33) . Serum TnI increases within 3-9 hrs after onset of myocardial cell injury and remains increased for 5-7 days in cases of massive myocardial cell death (30, (32) (33) (34) . The time course of TnI after more subtle forms of myocardial injury, such as during septic shock, is not well studied. Our study is the first pediatric series to demonstrate increased TnI in children with generalized septic shock. Our data are in agreement with those from adults with sepsis and septic shock, where 50 -80% of patients have increased TnI (17) (18) (19) (20) 35) . The only other available pediatric data regarding TnI during sepsis come from children with overwhelming meningococcal infection. Briassoulis and colleagues (36) showed that children with meningococcal septic shock had a significant increase in TnI. However, since a significant portion of the children in this study (23%) showed EKG findings consistent with myocardial ischemia and these children had much higher concentrations of serum TnI compared with those with a normal EKG, it is difficult to conclude that sepsis alone was the cause of the observed increase in TnI. In another series of children with meningococcal sepsis, Thiru and colleagues (16) found that TnI was increased on admission to a similar degree as we have found in generalized septic shock (24% on admission, 62% within the first 2 days of illness) but ischemic heart disease was not excluded in these children. Since vascular thrombi are pathologic sequelae of meningococcal sepsis syndrome, it seems likely that occult thromboses of coronary arteries in meningococcal disease could be responsible for the TnI increases observed in these previous studies. Since none of our patients had either meningococcal sepsis or signs of purpura fulminans, our data demonstrate that all forms of sepsis can cause increased TnI, particularly early after sepsis begins. This suggests that myocardial cell injury could be an important factor in the pathogenesis of septic shock in children.
We found that increased admission TnI was associated with decreased admission EF and FS, suggesting that increased TnI is associated with decreased measures of systolic cardiac function. Echocardiography can measure or estimate important variables of cardiac systolic performance (heart rate, cardiac loading conditions [preload and afterload] and cardiac contractility) (23, 37, 38) . Wall stress analysis and ejection phase indexes allow for hemodynamic calculations that account for physiologic conditions, which influence ventricular performance. These analyses can help to distinguish patients who have impaired contractility from patients who have altered loading conditions (8, 24, 39) . In our study, increased TnI was associated with decreased EF and FS and increased WS. Despite this association, most of the patients had values of systolic function within the generally accepted normal range for children who are not critically ill. On average, EF was decreased by 10% and FS was decreased by 20% in the TnIpositive compared with the TnI-negative patients.
The preload and afterload on the heart can significantly affect EF and FS. We performed the load independent assessments of Vcf c and WS. Vcf c is a heart rate and preload independent calculation of systolic function and WS is a measure of afterload. These analyses have been validated in the pediatric septic shock population (8) . Overall, we demonstrated a very close association between admission Heart rate corrected mean velocity of circumferential fiber shortening (Vcf c ) was decreased and wall stress (WS) was increased in TnI-positive children compared with TnI-negative children (data represented as mean Ϯ SEM, Student's t-test). Other variables were not different, but trends were observed in ejection fraction (EF), fractional shortening (FS), and the number of organ system failures (OSF).
TnI and WS but failed to demonstrate such a relationship with Vcf c . However, when patients were stratified into groups, TnI-positive patients had a lower mean Vcf c and a higher WS compared with the TnI-negative patients. This finding provides the best evidence that within a model that is not affected by loading conditions, patients with evidence of myocardial cell injury early in septic shock also have evidence of impaired ventricular contractility and increased cardiac afterload.
We found that increased admission TnI was associated with increased severity of illness measured by PRISM III and numbers of organ that fail during sepsis. This is the first study in either adults or children with sepsis to associate TnI with both of these longer term outcome variables. This finding is particularly intriguing because the TnI on admission was associated with of illness severity (PRISM III) and eventual organ dysfunction (OSF). This finding, if confirmed in larger series, suggests that screening children with sepsis for TnI can be of value in assessing the eventual outcome and suggests that early myocardial cell injury and death may contribute to the development of subsequent organ failure in pediatric patients with septic shock.
There are several limitations of our study. The mortality rate of the study patients was very low primarily because of our selection criteria. We used rigid entry criteria to avoid the bias of entering children with primary heart disease. Because of this, children with severe cardiac involvement from sepsis could not be definitively differentiated from patients with severe myocarditis or other primary heart diseases. As a result of these entry criteria, we have demonstrated that sepsis alone can cause an increase in this extremely sensitive marker of myocardial cell injury. A consequence of this process was to eliminate children with extreme perturbations in cardiac performance, and therefore the observed mortality rate was much lower than in previous studies. There are well-recognized limitations of echocardiography to quantitatively assess cardiac dysfunction that affect our results. We assessed left ventricular systolic performance only and could not account for the right ventricular or diastolic dysfunction that may occur in children with septic shock. Also, echocardiography uses geometric assumptions of the left ventricle that may vary between patients. Despite this, we were able to find important correlations between TnI and echocardiographic findings by using carefully chosen variables that were independent of loading conditions of the heart. It is possible that inadequate fluid resuscitation and excessive vasoconstrictive agents may contribute to the increased wall stress found in our patients. A more detailed study including patients with sepsis undergoing cardiac catheterization could aid in answering this question. Last, PRISM III and OSF are statistically linked measures of disease severity. By necessity, multiple laboratory values used in the PRISM III calculation are also used as definitions for OSF. So although our findings suggest that TnI is linked to both measures, a larger series of patients may be able to determine whether particular abnormalities are associated with admission TnI.
CONCLUSIONS
By using the biochemical marker TnI, our study suggests that myocardial cell injury may play a role in the myocardial dysfunction in pediatric patients with septic shock. TnI levels were frequently elevated in our pediatric population with septic shock. Increased admission TnI levels were associated with lower values of systolic cardiac function as measured by echocardiography and correlated with severity of illness. Early myocardial cell injury may contribute to the development of subsequent organ failure in septic shock, and measuring TnI on admission may help clinicians assess the degree of illness in children with sepsis. 
